Medidata Expands Partnership with BeiGene for ePRO Solution
NEW YORK - July 24, 2017 - Medidata, a global provider of cloud-based technology and data analytics for clinical research, announced that BeiGene, Ltd., a clinical-stage biopharmaceutical company developing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer, will expand its use of the Medidata Clinical Cloud® to further digitize patient reporting for its oncology research studies.
BeiGene will leverage Medidata’s integrated platform to feed eSource Patient Reported Outcome data from Medidata’s Patient Cloud ePRO directly into Medidata Rave®. This infusion of patient recorded outcome data will enable improved operational efficiency, reduced transcription errors and reconciliation issues, and decreased data quality risk plans.
“Our expanded partnership with Medidata will establish a technology platform for our clinical research, which we expect will enable us to more efficiently execute clinical trials of our portfolio compounds,” said Ross Pettit, Senior Vice President of Global Development Operations at BeiGene. “Over the past two years, Medidata has proven to be a key technology partner for BeiGene, with its industry-leading solutions and hands-on approach to our integration needs. By automating paper-based procedures and centralizing patient data on the Medidata platform, we’re able to collaborate globally on our oncology research.”
As part of its expanded partnership with Medidata, BeiGene also plans to standardize the collection and management of safety cases through Medidata Safety Gateway®, a secure, configurable electronic transmission interface between EDC and safety systems. The partnership between BeiGene and Medidata also includes Medidata Coder®, a cloud application that is designed to streamline and centralize medical coding to perform oncology research studies.
“Medidata is proud to be accelerating technology advancement at every level and interaction within the life sciences industry,” said Kara Dennis, Managing Director of Mobile Health at Medidata. “We’ve created an environment that is agile, globally collaborative, and in line with the digital and mobile needs of biotechnology and pharmaceutical companies, all from one unified cloud platform. BeiGene’s forward-thinking technology approach will enable faster study builds and centralized control over patient data, facilitating the evaluation of its portfolio compounds.”
Medidata Contacts
Investor: Anthony D’Amico, Medidata Solutions, +1 732-767-4331, adamico@mdsol.com
Media: Erik Snider, Medidata Solutions, +1 646-362-2997, esnider@mdsol.com
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
